IVI
IVI is a Valencia-headquartered private fertility clinic group founded in 1990, operating 30+ clinics across Spain and 9 countries. It offers IVF, ICSI, egg/sperm donation, fertility preservation, AI-assisted embryo selection, and ovarian rejuvenation, serving individual patients with a direct-to-consumer model.
- Company typePrivate
- Founded1990
- HeadquartersValencia, Spain
- Headcount1,001–5,000
- GTM typeB2C
- OfferingServices
What IVI does
IVI (Instituto Valenciano de Infertilidad) is a Valencia-headquartered private fertility clinic group founded in 1990 as the first Spanish clinic dedicated entirely to assisted reproduction. The company operates a direct-to-consumer reproductive medicine platform spanning 30+ clinics across Spain and country-specific operations in nine countries (Portugal, Brazil, Chile, Germany, France, Italy, Panama, Russia, and the UK), supported by 3,000+ professionals and reported 250,000+ babies born since inception. Its clinical portfolio covers the full assisted reproduction stack — artificial insemination, IVF, ICSI, egg and sperm donation, fertility preservation (vitrification), preimplantation genetic testing (PGT/PGT-A), and specialty units in reproductive immunology, endometriosis, andrology, and reproductive surgery.
The proprietary technology layer includes IA EMBRYOSELECT (computer-vision embryo selection), Perfect Match 360° + Biometric Scan (biometric embryo-endometrium matching), and Ovarian Rejuvenation techniques (OFFA — Ovarian Fragmentation for Follicular Activation, and BMDSC — Bone Marrow-Derived Stem Cells) developed with Hospital La Fe de Valencia. The business operates what it describes as one of the world's largest egg banks, alongside dedicated donor recruitment platforms (IVI Dona, IVI Dono) and diagnostic packages. Quality credentials include ISO 9001 (since 2007), UNE 179007 and UNE 179003 certifications audited by SGS, and SEF Collaborating Center status; reported success rates run 23% above the Spanish national average per SEF data.
IVI's revenue model combines per-treatment professional service fees with consumer financing products: IVI BABY (a multi-cycle guarantee program with refund if unsuccessful), IVI Contigo (customized multi-cycle plans), and 0%-interest financing up to 24 months. Customer acquisition runs through owned digital channels (SEO, blog, podcast, localized forums in seven languages, patient portal) plus event-driven Fertility Day webinars. The group sits under the legal entity Equipo IVI, S.L., with operating subsidiaries including IVIRMA Global Education, IVIRMA Innovation, IVI Dona, and IVI Dono. In 2025, Equipo IVI executed a USD 400 million acquisition of ART Fertility Clinics, expanding into the Middle East market.
IVI firmographics
Firmographics- Name
- IVI
- Legal name
- Equipo IVI, S. L.
- Website
- https://ivi.es
- Company type
- Private
- Founded year
- 1990
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- IVI is a Valencia-headquartered private fertility clinic group founded in 1990, operating 30+ clinics across Spain and 9 countries. It offers IVF, ICSI, egg/sperm donation, fertility preservation, AI-assisted embryo selection, and ovarian rejuvenation, serving individual patients with a direct-to-consumer model.
- Ownership category
- akta.pro rank
IVI industry classification
Industry- Product category
- Reproductive Medicine and Fertility Services
- NAICS
- Family Planning Centers (621410), Family Planning Centers (62141), Blood and Organ Banks (621991)
- SIC
- Services-Specialty Outpatient Facilities, Nec (8093), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)
- akta.pro secondary industries
- Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC), Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ), Fertility & Reproductive Endocrinology Telehealth (IVF/IUI, infertility evaluation) (HLALAHAA), Genetic, Cytogenetic & Prenatal Screening IVD (HLAHAAAI)
Keywords
Where IVI is headquartered
LocationHeadquarters
- HQ city
- Valencia
- HQ country
- Spain
- HQ region
- Europe
Offices28 records
Markets served
IVI business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales
Revenue model
- Fertility Treatment Services: Direct medical service fees for assisted reproduction treatments including IVF, ICSI, artificial insemination, egg donation, sperm donation, and fertility preservation. Revenue generated through clinical procedures and medical consultations.
- Treatment Financing: IVI offers internal financing plans (IVI BABY, IVI Contigo) allowing patients to spread treatment costs over up to 24 months with 0% interest and no commissions.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Pay-as-you-go | Free Ovarian Reserve Testing |
| Subscription | Multi-year contract | IVI BABY Guarantee Plan |
| Subscription | Multi-year contract | IVI Contigo Custom Plan |
| Other | Monthly | Treatment Financing |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels7 records
IVI product offering
Product offeringCore offering
IVI (Instituto Valenciano de Infertilidad) operates a network of fertility clinics providing assisted reproduction treatments including artificial insemination, in vitro fertilization (IVF), ICSI, egg donation (Ovodonación), the ROPA method for female couples, and fertility preservation via egg/embryo vitrification. The clinics deliver advanced procedures supported by proprietary technologies such as AI-powered embryo selection (EMBRYOSELECT), preimplantation genetic testing (PGT-A), ovarian rejuvenation (OFFA/BMDSC), and MACS sperm selection, complemented by diagnostic packages, genetic carrier screening, non-invasive prenatal testing, and in-house financing/guarantee programs (IVI BABY, IVI Contigo).
Product overview
IVI (Instituto Valenciano de Infertilidad) operates as a fertility clinic network offering a comprehensive portfolio of assisted reproduction treatments. The core offerings include Inseminación Artificial (IA), Fecundación in Vitro (FIV), Método ROPA for female couples, and Ovodonación. AI-enhanced features include IA EMBRYOSELECT for computer vision-based embryo selection and Perfect Match 360° for biometric matching. Advanced services span fertility preservation (egg vitrification), preimplantation genetic testing (PGT/PGT-A), ovarian rejuvenation treatments, and reproductive surgery. Supporting services include diagnostic packages (Pack Diagnóstico), payment plans (IVI Contigo), and a money-back guarantee program (IVI BABY). The network maintains patient-facing digital tools including a mobile app and patient portal.
Differentiator
Problem solved
Functional benefit
Brands
- IVI BABY: Guarantee program ensuring pregnancy or money back
- IVI Contigo
- IVI Dona
- IVI Dono
- Preserva
- FIV Genetic
Products and services
- Inseminación Artificial (IA) / Artificial Insemination Artificial insemination procedure using donor or partner sperm, intended for patients with viable fallopian tubes and adequate sperm parameters seeking less invasive first-line fertility treatment.
- Fecundación in Vitro (FIV) / In Vitro Fertilization (IVF) In vitro fertilization procedure combining eggs and sperm in the laboratory to create embryos for transfer, intended for couples and individuals with infertility not resolved by artificial insemination.
- Método ROPA / ROPA Method (Shared Motherhood) IVF-based shared motherhood treatment in which one female partner provides the eggs and the other partner carries the pregnancy, designed for female couples who want shared biological involvement.
- Ovodonación / Egg Donation IVF IVF treatment using eggs from carefully screened anonymous donors, intended for patients with diminished ovarian reserve, advanced maternal age, premature ovarian failure, or genetic concerns.
- Preserva de la fertilidad / Fertility Preservation Fertility preservation service through egg or embryo vitrification for women wishing to delay motherhood for personal, professional, or medical reasons (including oncology patients).
- ICSI (Microinyección espermática) / Intracytoplasmic Sperm Injection Advanced IVF technique in which a single sperm is directly injected into the egg, intended for cases of severe male-factor infertility, previous fertilization failure, or limited sperm availability.
- Vitrificación de ovocitos / Egg Vitrification Cryopreservation technique for oocytes using ultra-rapid vitrification with high post-thaw survival rates, used for fertility preservation and oocyte accumulation strategies.
- Centro de Excelencia en Rejuvenecimiento Ovárico / Ovarian Rejuvenation Center of Excellence Specialized unit offering OFFA (Ovarian Fragmentation for Follicular Activation) and BMDSC (Bone Marrow-Derived Stem Cells) infusion techniques for patients with low ovarian reserve or premature ovarian failure.
- Test Genético Preimplantacional (PGT) / Preimplantation Genetic Testing Preimplantation genetic testing of embryos for aneuploidy (PGT-A), monogenic disorders (PGT-M), or structural rearrangements (PGT-SR) prior to transfer, intended for couples with genetic risk factors or recurrent miscarriage.
- Test de Compatibilidad Genética (CARRIER Expanded) / Expanded Carrier Screening Expanded genetic compatibility test screening partners for hundreds of inherited conditions before conception, intended for couples planning pregnancy or starting IVF.
- Test prenatal no invasivo (Neo 24) / Non-Invasive Prenatal Test (NIPT) Non-invasive prenatal test analyzing fetal DNA from maternal blood from 10 weeks of gestation, intended for pregnant patients to screen for common chromosomal abnormalities.
- IVI BABY Guarantee Program Money-back guarantee program in which patients receive a full refund of treatment costs if the treatment does not result in a successful pregnancy, intended to reduce financial risk for patients committing to IVF.
- IVI Contigo Custom Plan Customized payment plan tailored to individual patient circumstances, allowing patients to spread fertility treatment costs over installment periods.
- Banco de Óvulos / Egg Bank One of the world's largest egg banks supplying rigorously screened anonymous donor eggs for Ovodonación treatments and recipient matching.
- Pack Diagnóstico / Diagnostic Package Initial fertility diagnostic package combining hormonal analysis, ovarian reserve testing, and a specialist consultation to assess fertility status and recommend a treatment pathway.
Quantifiable outcome
- Success rates 23% above national average (audited by SGS and presented annually to SEF)
- +3 more outcomes
Companies that use IVI
Customer profileNamed customers4 records
Segments6 records
Ideal customer profiles6 records
IVI technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature8 records
IVI partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered minor and core.
- CEPI (Coalition for Epidemic Preparedness Innovations)minorIVI participated as an industry partner in a pandemic simulation exercise organized by CEPI in collaboration with Korean parliamentary forums and government agencies. The seminar discussed how AI can transform health Official Development Assistance and strengthen Korea's role in vaccine R&D and pandemic preparedness.
- Hospital La Fe de ValenciacoreCollaborative research partnership for ovarian rejuvenation techniques. IVI and Hospital La Fe jointly conducted studies on OFFA (Ovarian Fragmentation for Follicular Activation) and BMDSC (Bone Marrow-Derived Stem Cells) infusion techniques. The collaboration resulted in 4 successful pregnancies in patients with premature ovarian failure. Research results were presented at the 7th International IVI Congress.
Scale indicators7 records
Recent moves6 records
Expansion highlights6 records
IVI competitors and assessment
Company assessmentDirect peers
- Eugin: Eugin is a Spain-headquartered fertility clinic network operating across Europe and Latin America with a similar multi-clinic, cross-border patient model to IVI. It is one of IVI's most direct Spanish and European competitors in IVF, egg donation, and fertility preservation.
- Genea: Genea is a global fertility clinic and IVF technology group headquartered in Australia with clinics in Australia, the UK, and other markets. Like IVI, it combines a multi-country clinic network with proprietary lab technology and a strong reproductive genetics offering.
- Virtus Health: Virtus Health is one of the largest fertility clinic networks globally, operating in Australia, the UK, Ireland, and Singapore. Its scale, multi-country footprint, and full-service IVF + diagnostics model make it a close international comparable to IVI.
- Monash IVF: Monash IVF is an Australian-listed fertility clinic group with clinics across Australia and Southeast Asia. It shares IVI's full-cycle reproductive medicine offering (IVF, ICSI, PGT, fertility preservation) and comparable research-driven brand positioning.
- Inception Fertility: Inception Fertility is the largest fertility services provider in the United States, operating multiple clinic brands and a frozen egg bank. Its multi-brand clinic roll-up model, donor egg assets, and tech-enabled offering mirror IVI's IVIRMA network strategy.
- Reproclinic: Reproclinic is a Barcelona-based fertility clinic specializing in IVF, egg donation, and reproductive genetics for both domestic and international patients. It is a direct Spanish competitor to IVI with overlapping services including PGT and shared motherhood treatments.
- Bourn Hall Clinic: Bourn Hall is the UK's first IVF clinic and operates a multi-site fertility network across the UK. Like IVI, it combines a long-established clinical brand with full-service IVF, ICSI, and donor programs serving both domestic and international patients.
Broad incumbents
- Dexeus Mujer: Dexeus Mujer is a large Barcelona-based women's health provider offering fertility, obstetrics, and gynecology services within a broader hospital-affiliated network. It competes with IVI in Catalonia and Spain but operates as part of a wider women's health portfolio rather than a pure-play fertility chain.
Emerging players
- Progyny: Progyny is a US fertility benefits and care platform that contracts with employer-sponsored patients and partner clinics. It targets the same end-patients as IVI (couples and individuals seeking IVF) but through a payer-led, technology-enabled model rather than owned clinics.
Others
- CooperSurgical: CooperSurgical is a global supplier of ART devices, consumables, media, and genetic testing services to IVF clinics. It is adjacent to IVI's operations as an enabling vendor across embryology, PGT, and cryopreservation rather than a direct clinic competitor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
IVI social profiles
Digital presenceIVI compliance and trust
Trust signalCompliance2 records
IVI financial estimates
Financial estimateRevenue estimate
Valuation estimate
IVI leadership team
Management profileNumber of profiles
Profiles4 records
IVI subsidiaries and ownership
Company hierarchySubsidiaries4 records
IVI funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
IVI M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about IVI
What does IVI do?
IVI (Instituto Valenciano de Infertilidad) operates a network of fertility clinics providing assisted reproduction treatments including artificial insemination, in vitro fertilization (IVF), ICSI, egg donation (Ovodonación), the ROPA method for female couples, and fertility preservation via egg/embryo vitrification. The clinics deliver advanced procedures supported by proprietary technologies such as AI-powered embryo selection (EMBRYOSELECT), preimplantation genetic testing (PGT-A), ovarian rejuvenation (OFFA/BMDSC), and MACS sperm selection, complemented by diagnostic packages, genetic carrier screening, non-invasive prenatal testing, and in-house financing/guarantee programs (IVI BABY, IVI Contigo).
Is IVI a public or private company?
IVI is a private company. It is classified as unknown and is currently operating.
When was IVI founded?
IVI was founded in 1990. It employs 1,001 to 5,000 people.
Where is IVI based?
IVI is headquartered in Valencia, Spain, in the Europe region.
How does IVI make money?
Two revenue lines are on record. Fertility Treatment Services are the primary driver. The others are treatment Financing.
Who are IVI's main competitors?
Direct peers on record are Eugin, Genea, Virtus Health, Monash IVF, Inception Fertility, Reproclinic and Bourn Hall Clinic. Dexeus Mujer is listed as a broad incumbent. Progyny is listed as an emerging player. CooperSurgical is listed as an others.
Does IVI have an API?
No public API is recorded for IVI.
What industry is IVI in?
IVI's product category is Reproductive Medicine and Fertility Services. Its primary akta.pro industry code is HLAFAJAD, Fertility, Reproductive Endocrinology & IVF Centers, with a secondary code of HLAKAJAC, Reproductive Endocrinology & Infertility (IVF/Fertility). Its NAICS code is 621410 and its SIC code is 8093.